Lung Cancer | Tumor

CURE’s lung cancer page is an extensive resource of cancer information featuring the latest lung cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on lung cancer.

When Patients With Cancer Become Advocates, Then ‘Everything Changes’

October 14th 2022

Patients with lung cancer must be educated about their disease in their native language to become better advocates for themselves, an expert explained.

Don't Let a Good Doctor Go: My Pediatrician Helped Guide Me Through Cancer

October 14th 2022

I sent all my cancer scans to my pediatrician, who combined the power of science with the power of belief and helped me through the difficult time.

NBA’s Kevin Durant Releases Cancer Shoe, Khloe Kardashian Discusses Melanoma and More

October 14th 2022

From Kevin Durant’s sneaker that is raising money for cancer to Khloe Kardashian’s urging people to check for moles and melanoma, here’s what’s happening in the cancer space this week.

Educated Patient® Lung Cancer Summit Molecular Testing and Adjuvant Targeted Therapies Presentation: October 1, 2022

October 14th 2022

Watch Dr. Anne Chiang, from Yale School of Medicine, discuss molecular testing and adjuvant targeted therapies during the CURE Educated Patient Lung Cancer Summit.

Educated Patient® Lung Cancer Summit Neoadjuvant Versus Adjuvant Therapy Presentation: October 1, 2022

October 13th 2022

Watch Dr. Jared Weiss, from UNC School of Medicine, discuss neoadjuvant versus adjuvant therapy during the CURE Educated Patient Lung Cancer Summit.

I No Longer Run from My Cancer Diagnosis

October 10th 2022

I went from being an avid runner to running from information about my lung cancer. But now I embrace my diagnosis and am an active participant in my care.

Beyond the Walls of Lung Cancer

October 8th 2022

An oncology nurse and cancer survivor inspired another person with lung cancer to “continue the fight to live.”

A Lung Cancer Hero Is the Doctor ‘Every Oncologist Should Strive to Be’

October 7th 2022

Dr. Estelamari Rodriguez serves patients with lung cancer in more than just a clinical capacity, her Lung Cancer Hero® nominator wrote.

Multi-Chemotherapy Regimen Elicits Improved Outcomes in Rare Form of Pediatric Lung Cancer, But More Research is Needed

October 6th 2022

The use of a multi-agent chemotherapy regimen resulted in improved outcomes in a group of children with pleuropulmonary blastoma, a rare form of lung cancer, when compared with other regimens.

Lung Cancer Survivor Urges Others to Participate in Research, Says it ‘Will Make a Difference in the Future’ of Others

October 5th 2022

A breast cancer research nurse and lung cancer survivor stresses the importance of participating in clinical trials that are investigating the latest treatments.

FDA Fast Tracks Investigational Drug for Potential Approval in Lung Cancer Subtype

October 4th 2022

Treatment with an investigational drug elicited a median progression-free survival (time from treatment until disease progression or death) of 8.9 months among patients with a form of unresectable or metastatic squamous non-small cell lung cancer, according to trial findings.

Lung Cancer Space Must ‘Maximize’ the People Who Benefit From Advancements

October 3rd 2022

Lung cancer advocates and clinicians must ”fight” for every patient with the disease and ensure that the most amount of people can benefit from advancements in the field, according to an advocate.

Mississippi's Lung Cancer Hero

October 2nd 2022

Dr. Pierre de Delva works tirelessly to bring better outcomes to patients with lung cancer who live in Mississippi — a state that traditionally has poor lung cancer outcomes.

Cancer Taught Me Some Unexpected Lessons

September 29th 2022

After being diagnosed with late-stage cancer, I learned many lessons, including the fact that I had to be my own best advocate.

FDA Approves Avastin Biosimilar to Treat Six Diseases Including Certain Colon, Lung, Kidney Cancers

September 28th 2022

The FDA’s approval of Vegzelma was based on data that demonstrated the biosimilar elicited comparable safety and efficacy to Avastin in several studies.

Early-Phase Trial to Study Novel Drug, With or Without Keytruda, in Solid Cancers

September 27th 2022

The novel drug PY159 will be studied as a single agent and in combination with Keytruda for patients with certain solid tumors — including ovarian, pancreatic, lung, head and neck, colorectal and breast cancers.

CURE® Lung Cancer Heroes® Award Program Showcases 3 Individuals Who Significantly Transformed the Space

September 24th 2022

CURE®’s Lung Cancer Heroes® Award Program honors and gives thanks to those heroes who have positively affected the lives of patients with lung cancer.

FDA Grants Retevmo Full Approval for RET Fusion-Positive Lung Cancer Treatment

September 22nd 2022

The Food and Drug Administration approved Retevmo for the treatment of patients with advanced or metastatic non-small cell lung cancer with a rearranged RET gene fusion.

Diminished Sexual Health Should Not Be a Price Paid to Survive Lung Cancer

September 21st 2022

Three out of four women with lung cancer reported experiencing moderate to severe sexual dysfunction, a survey shows.

Lumakras Improves Outcomes, Quality of Life in Patients With Lung Cancer Subtype

September 14th 2022

Lumakras outperformed chemotherapy in reducing the risk of progression or death and improving quality of life for patients with KRAS G12C-mutated non-small cell lung cancer, study results showed.

FDA’s Enhertu Approval is ‘Even More Important’ for a Group of Patients With Difficult to Treat Lung Cancer, Says Expert

September 13th 2022

An expert discusses what patients need to know about the recent FDA approval of Enhertu for HER2-mutant non-small cell lung cancer, an aggressive subtype of the disease.

Cancer Made Me Feel Invisible as I Was the Sickest Girl in Every Room

September 12th 2022

When going through treatment for advanced-stage lung cancer, people would often talk to me like I was a child, or ignore me altogether and speak to my husband.

Novel Drug Will Be Evaluated for EGFR-TKI—Mutant Lung Cancer

August 31st 2022

The first patient has been treated with H002, a novel drug being investigated for non-small cell lung cancer that is resistant to a prior EGFR TKI treatment.

Novel Drug Bests Tagrisso in Heavily Pretreated Lung Cancer

August 25th 2022

More patients with pretreated non-small cell lung cancer saw their disease disappear with abivertinib compared to Tagrisso.

I Refused to Let My Stage 4 Cancer Be a Death Sentence

August 23rd 2022

When doctors told me that there was no more they could do for my stage 4 lung cancer, I refused to believe them, and wish other patients did the same.

FDA Grants Accelerated Approval to Enhertu for Subgroup of Patients With Unresectable or Metastatic Non-Small Cell Lung Cancer

August 11th 2022

The FDA’s approval of Enhertu marks the first approval of a drug for patients with HER2-mutant unresectable or metastatic non-small cell lung cancer.

FDA Grants Tabrecta a Regular Approval for Certain Patients With Lung Cancer

August 11th 2022

The FDA approved Tabrecta for patients with non-small cell lung cancer who have a mutation that led to MET exon 14 skipping.

Two-Drug Combo Bests Chemotherapy in Front-Line Lung Cancer Treatment

August 10th 2022

Imfinzi plus tremelimumab led to better overall survival outcomes compared to standard chemotherapy in patients with metastatic non-small cell lung cancer.

EGFR C797X Mutation May Lead to Tagrisso Resistance in Patients With Lung Cancer

August 9th 2022

According to real-world data, EGFR C797X mutation is deemed the leading resistance mechanism to treatment with Tagrisso in patients with non-small cell lung cancer.

Sugemalimab Demonstrates Improved Progression-Free Survival in Some Patients with Non-Small Cell Lung Cancer

August 9th 2022

Sugemalimab demonstrated safe and efficacious results when given after concurrent chemoradiation therapy or short-course chemoradiation therapy for patients with lung cancer.